Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Alkylating Activity [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
BENDAMUSTINE 19,667 3,988 20.3% 7,576 1,197 65.5 yrs 40.1%
TEMOZOLOMIDE 17,007 3,099 18.2% 4,302 666 49.4 yrs 45.9%
IFOSFAMIDE 17,004 3,365 19.8% 5,230 1,404 36.2 yrs 41.7%
MELPHALAN 16,061 3,369 21.0% 4,615 1,365 48.1 yrs 43.8%
BUSULFAN 11,254 3,122 27.7% 2,271 892 27.6 yrs 41.3%
THIOTEPA 6,836 1,867 27.3% 1,184 609 25.7 yrs 44.5%
PROCARBAZINE 6,373 829 13.0% 1,132 204 48.0 yrs 44.7%
DACARBAZINE 5,105 847 16.6% 1,914 379 45.5 yrs 47.8%
CARMUSTINE 3,376 781 23.1% 873 399 52.0 yrs 33.8%
MECHLORETHAMINE 2,579 266 10.3% 291 14 63.7 yrs 47.0%

Head-to-Head Comparisons

BENDAMUSTINE vs TEMOZOLOMIDE BENDAMUSTINE vs IFOSFAMIDE BENDAMUSTINE vs MELPHALAN BENDAMUSTINE vs BUSULFAN TEMOZOLOMIDE vs IFOSFAMIDE TEMOZOLOMIDE vs MELPHALAN TEMOZOLOMIDE vs BUSULFAN IFOSFAMIDE vs MELPHALAN IFOSFAMIDE vs BUSULFAN MELPHALAN vs BUSULFAN
← Back to Alkylating Activity [MoA] Class side effects →